A NEW GENE THERAPY PARADIGM IN VIVO CRISPR ENGINEERING OF HEMATOPOIETIC NICHES FOR CANCER IMMUNOTHERAPY. FMHR [Internet]. 2026 Jun. 21 [cited 2026 Aug. 28];4(6):1756-802. Available from: https://fmhr.net/index.php/fmhr/article/view/3230